CW
CVS icon

Cabot-Wellington’s CVS Health CVS Stock Holding History

Cabot-Wellington’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-123,522
Closed -$12.8M – 21
2016
Q1 		$12.8M Sell
123,522
-11,084
-8% -$1.08M 9.44% 4
2015
Q4 		$13.2M Sell
134,606
-500
-0.4% -$49K 8.94% 4
2015
Q3 		$13M Sell
135,106
-930
-0.7% -$97.8K 7.84% 3
2015
Q2 		$14.3M Sell
136,036
-1,945
-1% -$199K 7.03% 4
2015
Q1 		$14.2M Sell
137,981
-2,705
-2% -$274K 6.05% 5
2014
Q4 		$13.5M Sell
140,686
-1,555
-1% -$137K 5.03% 5
2014
Q3 		$11.3M Hold
142,241
– – 4.2% 10
2014
Q2 		$10.7M Sell
142,241
-525
-0.4% -$39.7K 3.79% 12
2014
Q1 		$10.7M Buy
142,766
+325
+0.2% +$23K 3.99% 10
2013
Q4 		$10.2M Buy
142,441
+250
+0.2% +$16.1K 3.74% 10
2013
Q3 		$8.07M Buy
142,191
+2,050
+1% +$122K 3.16% 14
2013
Q2 		$8.01M Buy
+140,141
New +$8.12M 3.36% 14

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cabot-Wellington's CVS Position: Q2 2016 in Review

Cabot-Wellington sold out of CVS Health (CVS) in Q2 2016, closing a stake of 123,522 shares — an estimated $12.8M sold.

Cabot-Wellington first reported a position in CVS in Q2 2013 and held it in 12 quarters. The position peaked at $14.3M in Q2 2015. 1,572 funds tracked by Wall St. Rank hold CVS as of Q2 2016.

  • Cabot-Wellington reported no remaining CVS Health position as of Q2 2016 after selling out during the quarter.
  • Cabot-Wellington sold 123,522 CVS Health shares in Q2 2016, an estimated $12.8M.
  • Cabot-Wellington first reported a position in CVS Health in Q2 2013 and held it in 12 quarters.
  • Cabot-Wellington's CVS Health position peaked at $14.3M in Q2 2015.
  • 1,572 funds tracked by Wall St. Rank held CVS Health as of Q2 2016.

Based on Cabot-Wellington's 13F filing for Q2 2016, filed 9 Aug 2016.